Abstract
Due to the ability to differentiate into numerous cell types, multipotent mesenchymal stem cells (MSCs) are currently researched widely including in the field of craniofacial tissues engineering where always requires a wide variety of cell types and tissues while complete surgical reconstruction of craniofacial tissues is always difficult to achieve based on conventional therapies due to such high complexity. Nowadays, numerous animal model studies have been reported on the effect of MSCs in craniofacial tissue engineering including bone, tendon, cartilage, cutaneous wound and vascularization repair etc. Several clinical trials also have been reported with inspiring results. In this review, we will summarize the recent progress of MSCs in craniofacial tissue engineering and the potential clinical application in future.
Keywords: Adipose stem cells, craniofacial reconstruction, mesenchymal stem cells, tissue engineering.
Current Stem Cell Research & Therapy
Title:The Effects of Mesenchymal Stem Cells in Craniofacial Tissue Engineering
Volume: 9 Issue: 3
Author(s): Lin Zhang, Ge Feng, Xing Wei, Lan Huang, Aishu Ren, Ni Dong, Huaqiao Wang, Qianqian Huang, Yi Zhang and Feng Deng
Affiliation:
Keywords: Adipose stem cells, craniofacial reconstruction, mesenchymal stem cells, tissue engineering.
Abstract: Due to the ability to differentiate into numerous cell types, multipotent mesenchymal stem cells (MSCs) are currently researched widely including in the field of craniofacial tissues engineering where always requires a wide variety of cell types and tissues while complete surgical reconstruction of craniofacial tissues is always difficult to achieve based on conventional therapies due to such high complexity. Nowadays, numerous animal model studies have been reported on the effect of MSCs in craniofacial tissue engineering including bone, tendon, cartilage, cutaneous wound and vascularization repair etc. Several clinical trials also have been reported with inspiring results. In this review, we will summarize the recent progress of MSCs in craniofacial tissue engineering and the potential clinical application in future.
Export Options
About this article
Cite this article as:
Zhang Lin, Feng Ge, Wei Xing, Huang Lan, Ren Aishu, Dong Ni, Wang Huaqiao, Huang Qianqian, Zhang Yi and Deng Feng, The Effects of Mesenchymal Stem Cells in Craniofacial Tissue Engineering, Current Stem Cell Research & Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574888X09666140213204202
DOI https://dx.doi.org/10.2174/1574888X09666140213204202 |
Print ISSN 1574-888X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3946 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Inhaled Insulin and the Lung
Current Medicinal Chemistry Nitric Oxide and Dietary Factors: Part II Cholesterol, Fat, Amino Acids,Proteins and Carbohydrate
Vascular Disease Prevention (Discontinued) Biologic Therapy in Inflammatory Immunomediated Systemic Diseases: Safety Profile
Current Drug Safety From Mars to Venus: Gender Differences in the Management and Outcomes of Acute Coronary Syndromes
Current Pharmaceutical Design A Simple Scoring Model Predicting the Outcome of COVID-19 Patients: Tanta COVID Score
Endocrine, Metabolic & Immune Disorders - Drug Targets MicroRNA-21 as Therapeutic Target in Cancer and Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Nano-Delivery in Pediatric Tumors: Looking Back, Moving Forward
Anti-Cancer Agents in Medicinal Chemistry Architecture and Conservation of the Bacterial DNA Replication Machinery, an Underexploited Drug Target
Current Drug Targets Antihypertensive Therapy in Children: Differences in Medical Approach Between the United States and Europe
Current Medicinal Chemistry Antihistamines: Past Answers and Present Questions
Current Drug Safety The Origins of Aging: Evidence that Aging is an Adaptive Phenotype
Current Aging Science Editorial (Hot Topic: No Reflow: What’s in a Name?)
Current Pharmaceutical Design Percutaneous Valve Interventions
Current Cardiology Reviews Idarucizumab: Clinical Role of a Novel Reversal Agent for Dabigatran
Cardiovascular & Hematological Disorders-Drug Targets Regulation of Iron Absorption in Hemoglobinopathies
Current Molecular Medicine Editorial: Herbal Medicine on High Impact Disease: The Current Progress and Application
Current Pharmaceutical Design Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?
Current Vascular Pharmacology MicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug Targets Dopexamine After Heart Surgery: An Uncommonly Used, Though Useful Inotropic Agent
Recent Patents on Cardiovascular Drug Discovery Phase II and Pharmacological Study of Oral Docetaxel Plus Cyclosporin A in Anthracycline Pre-Treated Metastatic Breast Cancer
Current Clinical Pharmacology